Clinician Summary
The US Preventive Services Task Force strongly recommends that clinicians routinely screen all sexually active women aged 25 years and younger, and other asymptomatic women at increased risk for infection, for Chlamydial infection
This reminder prompts clinicians to screen High Risk individuals who have the following recorded indicators within the electronic health record (EHR) system:
- gender is female; and
- age < 26 years old; and
- last record of Chlamydia test >12 months ago; and
- med list includes:
- ALESSE
- APRI
- AVIANE
- BREVICON
- CAMILA
- CYCLESSA
- DEMULEN 1/35
- DEMULEN 1/50
- DESOGEN
- ERRIN
- ESTROSTEP 21
- ESTROSTEP FE
- ETHINYL ESTRADIOL/NORETHINDRONE ACETATE
- ETHINYL ESTRADIOL/NORETHINDRONE ACETATE/FE
- LESSINA
- LEVLEN
- LEVLITE-21
- LEVLITE-28
- LEVONORGESTREL INTRAUTERINE SYSTEM
- LEVORA 0.15/30
- LEVORA 0.15/30-21
- LEVORA 0.15/30-28
- LO/OVRAL
- LOESTRIN 21 1.5/30
- LOESTRIN 21 1/20
- LOESTRIN FE 1.5/30
- LOESTRIN FE 1/20
- LO-OVRAL
- LOW-OGESTREL (28)
- MEDROXYPROGESTERONE
- MEDROXYPROGESTERONE INJ
- MICROGESTIN FE 1.5/30
- MICROGESTIN FE 1/20
- MIRCETTE
- MIRENA INTRAUTERINE SYSTEM
- MODICON
- NECON 0.5/35
- NECON 0.5/35-21
- NECON 1/35
- NECON 1/50
- NECON 10/11
- NORDETTE
- NORETHIN 1/35E
- NORETHIN 1/50M
- NORETHINDRONE ACETATE
- NORGESTREL
- NORGESTREL 0.5MG/ETHINYL ESTRADIOL 0.05MG
- NORINYL 1 + 50
- NORINYL 1+35
- NORINYL 1+50
- NOR-Q-D
- NUVARING
- ORTHO EVRA
- ORTHO MICRONOR
- ORTHO TRI-CYCLEN
- ORTHO TRI-CYCLEN LO
- ORTHO-CEPT
- ORTHO-CYCLEN
- ORTHO-NOVUM 1/35
- ORTHO-NOVUM 1/50
- ORTHO-NOVUM 10/11
- ORTHO-NOVUM 7/7/7
- OVCON-35
- OVCON-50
- OVRAL (MORNING AFTER PILL)
- OVRAL-21
- OVRAL-28
- PLAN B
- PORTIA
- SEASONALE
- TRI-LEVLEN
- TRI-NORINYL
- TRIPHASIL
- TRIVORA
- YASMIN
- ZOVIA 1/35
- ZOVIA 1/50
References
1. Hollblad-Fadiman K,GoldmanSM.AmericanCollegeof Preventive Medicine practice policy statement. Screening for Chlamydia trachomatis. Am J Prev Med 2003 Apr;24(3):287-92
- Berg AO. Screening for chlamydial infection. Recommendations and rationale. Am J Prev Med 2001 Apr;20(3 Suppl):90-4
Web Links
1. http://www.cdc.gov/std/Chlamydia/STDFact-Chlamydia.htm
2. http://www.cdc.gov/nchstp/dstd/HEDIS.htm
3. https://archive.ahrq.gov/clinic/ajpmsuppl/chlarr.htm
Implementation Notes
|
Rule category |
Chlamydia Screening |
|---|---|
|
Rule title |
Due for Chlamydia screen |
|
Primary Clinical Area |
Pediatrics |
|
Secondary Clinical Area |
|
|
Risk Group Definition |
gender is Female and age < 26 years old and med list includes:
|
|
Details for Risk Group |
med list contains OCP |
|
Triggering Condition |
last record of Chlamydia test >12 months ago
|
|
Details for Triggering |
check date of most recent Chlamydia test |
|
Condition |
Chlamydia |
|
Displayed Message |
Contraceptive is on medication list. If patient is sexually active, screen for Chlamydia.
|
|
Coded Responses |
Snooze Periods |
|
A: Chlamydia screen done today |
A': 12 months |
Disclaimer
These rules and/or reminders were created using national, state and local guidelines, and group consensus regarding best practices. These guidelines, and their interpretation by clinicians at Partners Healthcare System, may not represent the standard of care across all regions or settings, and are not intended to be adopted or applied without independent assessment of their suitability for a particular setting. Moreover, guidelines change over time (for example, the age range for children who should receive influenza vaccinations was recently extended to 59 months). The rules and/or reminders may need the addition or modification of certain items to ensure that they remain consistent with current guidelines. Therefore, the rules and/or reminders included here are intended only as examples or guides for the development of similar rules and/or reminders in other settings. Partners Healthcare System and its affiliates disclaim any and all responsibility or liability associated with the use of the rules and/or reminders displayed here by third parties.